$2.6 0%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 3 0%
Sentiment 75 N/A N/A
Webpage traffic 96,000 -1.2%
Employee Rating 79 0%
Google Adspend $20,191 101.8%
Google Trends 35 218.2%
Linkedin Employees 224 N/A
Patents 20 0%
4chan Mentions 0%
Facebook Engagement 172 -0.6%
Facebook followers 40,003 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 4,462 -0.1%
Twitter Followers 2,870 0%
Instagram Followers 4,766 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 52 -1.9%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Eargo

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States.

Price $2.6
Target Price Sign up
Market Cap $54M
Dividend Yield 0
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '238.3M22M4.3M-17M-18M
Q2 '238.1M29M1.6M-25M-26M
Q1 '2312M30M5.1M-22M-23M
Q4 '2239M33M6.2M-44M-24M
Q3 '2231M29M1.9M-51M-26M

Insider Transactions

Thorpe Mark filed to sell 1,064 shares at $3.2.
August 17 '23
Laponis Adam filed to sell 3,152 shares at $3.2.
August 17 '23
Brownie William filed to sell 6,779 shares at $3.2.
August 17 '23
Thorpe Mark filed to sell 1,067 shares at $4.7.
May 18 '23
Laponis Adam filed to sell 3,171 shares at $4.7.
May 18 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.